tiprankstipranks
Trending News
More News >
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT

Corcept Therapeutics (CORT) Revenue

Compare
1,235 Followers

Corcept Therapeutics Revenue

Corcept Therapeutics had a revenue of 207.64M in the quarter ending Sep 30, 2025, with 6.79%. This bring the company's revenue in the last twelve months to 741.17M, Decreased 3.50%. In the fiscal year ending Dec 31, 2024, Corcept Therapeutics had annual revenue of 675.04M with 39.94% growth.
Revenue (ttm)
741.17M
Revenue Growth
17.92%
P/S Ratio
13.71
Revenue/Employee
$1,350,080
Employees
500
Market Cap
$9.26B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
675.04M192.66M+139.94%
Dec 31, 2023
482.38M80.52M+120.04%
Dec 31, 2022
401.86M35.88M+109.80%
Dec 31, 2021
365.98M12.10M+103.42%
Dec 31, 2020
353.87M47.39M+115.46%
Dec 31, 2019
306.49M55.24M+121.99%
Dec 31, 2018
251.25M92.05M+157.82%
Dec 31, 2017
159.20M77.88M+195.77%
Dec 31, 2016
81.32M